Atenolol
- Product NDC
- 70934-177
- 11-digit product format
- 709340177
- Labeler code
- 70934
- Product ID
- 70934-177_f15da684-caef-5923-e053-2a95a90a07f8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atenolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA077443
- Marketing category
- ANDA
- Marketing start
- 2019-06-24
- Marketing end
- 2023-01-31
- Substance
- ATENOLOL
- Active strength
- 25 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-177-30 | 70934017730 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-177-30) | 30 tablet | 2019-12-05 | 0000-00-00 | No | No | Current |
| 70934-177-60 | 70934017760 | 60 TABLET in 1 BOTTLE, PLASTIC (70934-177-60) | 60 tablet | 2020-02-10 | 0000-00-00 | No | No | Current |
| 70934-177-90 | 70934017790 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-177-90) | 90 tablet | 2019-06-24 | 0000-00-00 | No | No | Current |